Polymorphism in INSR Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement Therapy

AIMS: Atrial fibrillation (AF) is a risk for patients receiving thyroid hormone replacement therapy. No published work has focused on pharmacogenetics relevant to thyroid dysfunction and AF risk. We aimed to assess the effect of L-thyroxine on AF risk stratified by a variation in a candidate gene. M...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Genet
Päätekijät: Soto-Pedre, Enrique, Siddiqui, Moneeza K., Maroteau, Cyrielle, Dawed, Adem Y., Doney, Alex S., Palmer, Colin N. A., Pearson, Ewan R., Leese, Graham P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Genetics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260687/
https://ncbi.nlm.nih.gov/pubmed/34249083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.652878
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia